Metavia INC. (MTVA) — DEF 14A Filings
All DEF 14A filings from Metavia INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
MetaVia Sets June 30 Annual Meeting, Board Elections on Tap
— Jun 10, 2025 Risk: low
MetaVia Inc. (MTVA) filed a DEF 14A on June 10, 2025, for its virtual 2025 Annual Meeting of Stockholders scheduled for June 30, 2025, at 10:00 a.m. Eastern Tim -
NeuroBo Pharmaceuticals Files Definitive Proxy Statement
— Aug 21, 2024 Risk: low
NeuroBo Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEF 14A) on August 21, 2024, for its fiscal year ending December 31, 2024. The company, former -
NeuroBo Pharmaceuticals Announces 2024 Annual Meeting of Stockholders
— Apr 30, 2024 Risk: low
NeuroBo Pharmaceuticals, Inc. (MTVA) filed a Proxy Statement (DEF 14A) with the SEC on April 30, 2024. NeuroBo Pharmaceuticals will hold its 2024 Annual Meeting
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX